The presence of FGFR genomic alterations, including FGFR2 fusions genes identified by NGS in 55 patients with intrahepatic cholangiocarcinoma, has been associated with an indolent disease course and prolonged survival [55]. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.